Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2) | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2)

Authors:: Chien-Yi Chan; Shih-Cing Hong; Chin-Ming Chang; Yuan-Hong Chen; Pin-Chen Liao; Chun-Yin Huang

Reference:: Cells; 2023; 12; 179

DOI:: 10.3390/cells12010179

See Abstract

Key Words:: Oral squamous cell carcinoma; ERL-R5; ERL-R10; erlotinib; quercetin; glycolytic enzyme; PKM2; mice; animal experiments

Back to index